ReWalk Robotics Ltd. (NASDAQ:RWLK – Get Rating)’s stock price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.96 and traded as high as $1.01. ReWalk Robotics shares last traded at $0.99, with a volume of 161,836 shares changing hands.
Several equities research analysts have weighed in on RWLK shares. HC Wainwright restated a “buy” rating on shares of ReWalk Robotics in a research note on Wednesday, May 18th. StockNews.com started coverage on ReWalk Robotics in a research note on Thursday, March 31st. They set a “sell” rating on the stock.
The company’s fifty day moving average is $0.96 and its two-hundred day moving average is $1.08. The company has a market cap of $62.17 million, a price-to-earnings ratio of -3.82 and a beta of 2.60.
ReWalk Robotics (NASDAQ:RWLK – Get Rating) last released its quarterly earnings data on Friday, May 13th. The medical device company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02). ReWalk Robotics had a negative net margin of 253.78% and a negative return on equity of 16.81%. The business had revenue of $0.88 million during the quarter, compared to analysts’ expectations of $2.20 million. During the same period last year, the company earned ($0.08) earnings per share. Analysts expect that ReWalk Robotics Ltd. will post -0.2 EPS for the current fiscal year.
In related news, major shareholder Global Fund Lp Lind II acquired 236,616 shares of ReWalk Robotics stock in a transaction on Thursday, June 2nd. The stock was acquired at an average price of $1.00 per share, for a total transaction of $236,616.00. Following the purchase, the insider now owns 4,092,022 shares of the company’s stock, valued at approximately $4,092,022. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders have acquired a total of 299,432 shares of company stock worth $302,733 over the last ninety days. 0.78% of the stock is owned by insiders.
Several large investors have recently bought and sold shares of the company. Hilltop Holdings Inc. acquired a new position in shares of ReWalk Robotics in the 4th quarter valued at $25,000. Renaissance Technologies LLC acquired a new position in shares of ReWalk Robotics in the first quarter worth about $35,000. HighTower Advisors LLC boosted its stake in shares of ReWalk Robotics by 60.0% during the 4th quarter. HighTower Advisors LLC now owns 80,000 shares of the medical device company’s stock worth $98,000 after acquiring an additional 30,000 shares in the last quarter. Finally, Advisor Group Holdings Inc. grew its position in shares of ReWalk Robotics by 76.9% during the 4th quarter. Advisor Group Holdings Inc. now owns 925,332 shares of the medical device company’s stock valued at $1,138,000 after acquiring an additional 402,225 shares during the period. 9.81% of the stock is owned by hedge funds and other institutional investors.
About ReWalk Robotics (NASDAQ:RWLK)
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.
Featured Articles
Receive News & Ratings for ReWalk Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ReWalk Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.